Fulton Bank’s Bristol-Myers Squibb BMY Stock Holding History

Fulton Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$605K	Buy	10,505 +1,811	+21%	+$104K	0.02%	438
2026 Q1	$527K	Buy	8,694 +241	+3%	+$14K	0.02%	434
2025 Q4	$456K	Sell	8,453 -3,978	-32%	-$191K	0.02%	472
2025 Q3	$561K	Sell	12,431 -2,288	-16%	-$107K	0.02%	403
2025 Q2	$681K	Sell	14,719 -40,783	-73%	-$2M	0.03%	360
2025 Q1	$3.39M	Sell	55,502 -6,747	-11%	-$393K	0.14%	110
2024 Q4	$3.52M	Buy	62,249 +3,062	+5%	+$171K	0.14%	112
2024 Q3	$3.06M	Buy	59,187 +7,410	+14%	+$348K	0.12%	127
2024 Q2	$2.15M	Sell	51,777 -14,862	-22%	-$665K	0.09%	167
2024 Q1	$3.61M	Buy	66,639 +20,846	+46%	+$1.06M	0.15%	109
2023 Q4	$2.35M	Sell	45,793 -3,031	-6%	-$159K	0.11%	153
2023 Q3	$2.83M	Buy	48,824 +2,837	+6%	+$174K	0.14%	120
2023 Q2	$2.94M	Buy	45,987 +2,846	+7%	+$191K	0.14%	124
2023 Q1	$2.99M	Buy	43,141 +54	+0.1%	+$3.81K	0.16%	118
2022 Q4	$3.1M	Sell	43,087 -6,019	-12%	-$454K	0.17%	112
2022 Q3	$3.49M	Sell	49,106 -9,420	-16%	-$683K	0.21%	87
2022 Q2	$4.51M	Sell	58,526 -8,951	-13%	-$682K	0.25%	67
2022 Q1	$4.93M	Buy	67,477 +34,773	+106%	+$2.33M	0.23%	72
2021 Q4	$2.04M	Buy	32,704 +13,137	+67%	+$771K	0.09%	159
2021 Q3	$1.16M	Buy	19,567 +5,370	+38%	+$354K	0.05%	215
2021 Q2	$949K	Sell	14,197 -1,018	-7%	-$66.4K	0.04%	232
2021 Q1	$961K	Sell	15,215 -16,505	-52%	-$1.03M	0.05%	224
2020 Q4	$1.97M	Sell	31,720 -1,784	-5%	-$110K	0.11%	145
2020 Q3	$2.02M	Buy	33,504 +8,158	+32%	+$491K	0.12%	124
2020 Q2	$1.49M	Sell	25,346 -19,245	-43%	-$1.15M	0.1%	155
2020 Q1	$2.49M	Buy	44,591 +1,818	+4%	+$111K	0.2%	97
2019 Q4	$2.75M	Buy	42,773 +15,858	+59%	+$908K	0.17%	111
2019 Q3	$1.36M	Sell	26,915 -204	-0.8%	-$9.59K	0.09%	164
2019 Q2	$1.23M	Sell	27,119 -1,400	-5%	-$65.2K	0.08%	178
2019 Q1	$1.36M	Sell	28,519 -118	-0.4%	-$5.88K	0.1%	164
2018 Q4	$1.49M	Sell	28,637 -1,920	-6%	-$103K	0.12%	141
2018 Q3	$1.9M	Buy	30,557 +8,722	+40%	+$518K	0.12%	139
2018 Q2	$1.21M	Sell	21,835 -153	-0.7%	-$8.26K	0.08%	173
2018 Q1	$1.39M	Sell	21,988 -741	-3%	-$47.7K	0.1%	154
2017 Q4	$1.39M	Buy	22,729 +1,144	+5%	+$71.6K	0.1%	156
2017 Q3	$1.38M	Sell	21,585 -356	-2%	-$20.8K	0.1%	146
2017 Q2	$1.22M	Sell	21,941 -572	-3%	-$31.1K	0.1%	148
2017 Q1	$1.22M	Sell	22,513 -3,536	-14%	-$194K	0.1%	144
2016 Q4	$1.52M	Buy	26,049 +794	+3%	+$43.4K	0.13%	127
2016 Q3	$1.36M	Sell	25,255 -1,545	-6%	-$99.2K	0.13%	128
2016 Q2	$1.97M	Sell	26,800 -1,094	-4%	-$77.3K	0.19%	109
2016 Q1	$1.78M	Buy	27,894 +12,996	+87%	+$820K	0.18%	111
2015 Q4	$1.02M	Buy	14,898 +1,864	+14%	+$123K	0.11%	152
2015 Q3	$772K	Sell	13,034 -1	-0%	-$63	0.09%	170
2015 Q2	$867K	Sell	13,035 -15	-0.1%	-$989	0.09%	168
2015 Q1	$842K	Sell	13,050 -107	-0.8%	-$6.7K	0.09%	171
2014 Q4	$776K	Sell	13,157 -14,545	-53%	-$820K	0.09%	167
2014 Q3	$1.42M	Sell	27,702 -63	-0.2%	-$3.15K	0.16%	104
2014 Q2	$1.35M	Sell	27,765 -502	-2%	-$24.7K	0.15%	115
2014 Q1	$1.47M	Sell	28,267 -1,783	-6%	-$94.9K	0.17%	105
2013 Q4	$1.6M	Sell	30,050 -4,473	-13%	-$228K	0.19%	101
2013 Q3	$1.6M	Sell	34,523 -25,136	-42%	-$1.1M	0.19%	98
2013 Q2	$2.67M	Buy	+59,659	New	+$2.59M	0.33%	70

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Fulton Bank's BMY Position: Q2 2026 in Review

Fulton Bank increased its Bristol-Myers Squibb (BMY) stake by 21% in Q2 2026, buying an estimated $104K and bringing the position to 10,505 shares worth $605K. The position accounts for 0.02% of the portfolio, ranked #438.

Fulton Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.93M in Q1 2022. 500 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Fulton Bank held 10,505 shares of Bristol-Myers Squibb worth $605K as of Q2 2026.
Fulton Bank bought 1,811 Bristol-Myers Squibb shares in Q2 2026, an estimated $104K.
Bristol-Myers Squibb made up 0.02% of Fulton Bank's portfolio in Q2 2026, its #438 holding.
Fulton Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Fulton Bank's Bristol-Myers Squibb position peaked at $4.93M in Q1 2022.
500 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.